Unique ID issued by UMIN | UMIN000014652 |
---|---|
Receipt number | R000017046 |
Scientific Title | A randomized controlled trial for improving QOL(quality-of-life) concerning knee joint in human |
Date of disclosure of the study information | 2014/07/27 |
Last modified on | 2014/12/10 20:57:07 |
A randomized controlled trial for improving QOL(quality-of-life) concerning knee joint in human
A randomized controlled trial for improving QOL(quality-of-life) concerning knee joint in human
A randomized controlled trial for improving QOL(quality-of-life) concerning knee joint in human
A randomized controlled trial for improving QOL(quality-of-life) concerning knee joint in human
Japan |
Healthy volunteer
Not applicable |
Others
NO
To investigate the effect of the product containing S-adenosyl methionine (SAMe) yeast on knee joint
Safety,Efficacy
Confirmatory
Pragmatic
Questionnaires(JKOM)
Physical examinations
Blood test
Urine test
Questionnaires(VAS, bodily sensation)
Interventional
Parallel
Randomized
Cluster
Double blind -all involved are blinded
Placebo
NO
3
Treatment
Food |
SAMe yeast: 0mg/day
Duration: 12weeks
SAMe yeast: 500mg/day
Duration: 12weeks
SAMe yeast: 2500mg/day
Duration: 12weeks
50 | years-old | <= |
74 | years-old | >= |
Male and Female
(1)Males and females aged 50 to 74 years old
(2)Subjects who feel discomfort and/or pain on knee joint within the last 6 month, and the discomfort and/or pain are still continuing
(1)Patients being treated for rheumatoid arthritis
(2)Subjects who have a weak stomach, be suspected of gastrointestinal disease and/or have diarrhea routinely
(3)Subjects who have previous medical history and/or current medical history of serious diseases (e.g., heart, liver, kidney, pancreas, and/or digestive organ)
(4)Subjects who have hypertension (not less than level 3)
(5)Subjects who continuously use anti-inflammatory agent or muscle relaxant
(6)Subjects who continuously use pack and/or topical cream etc. on knee and/or leg region
(7)Subjects who continuously use medicines and/or Chinese herbal medicine, and can't stop using during this trial
(8)Subjects who use functional foods that have mitigation or treatment effect for joint pain (e.g., amino acid, protein, vitamin D, chondroitin, collagen, and/or glucosamine), and can't stop using during this trial
(9)Subjects who have previous medical history of drug and/or food allergy
(10)Subjects with excessive alcohol-drinking behaviors
(11)Subjects who contract or are under treatment for psychiatric disorder
(12)Subjects who have been enrolled in the other clinical trials within about last 1 month
(13)Subjects who are judged as unsuitable for the trial by the investigator or subinvestigator for other reasons
45
1st name | |
Middle name | |
Last name | Katsuhisa SAKANO |
CPCC Company Limited
Clinical Research Planning Department
2F Chushin Build. 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047 Japan
03-5927-3112
cpcc-contact@cpcc.co.jp
1st name | |
Middle name | |
Last name | Makoto ICHINOHE |
CPCC Company Limited
Plan sales department
2F Chushin Build. 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047 Japan
03-5927-3112
cpcc-contact@cpcc.co.jp
CPCC Company Limited
Omnica Co., Ltd.
Profit organization
NO
チヨダパラメディカルケアクリニック(東京都)
2014 | Year | 07 | Month | 27 | Day |
Unpublished
Completed
2014 | Year | 07 | Month | 19 | Day |
2014 | Year | 07 | Month | 28 | Day |
2014 | Year | 07 | Month | 25 | Day |
2014 | Year | 12 | Month | 10 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017046